SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-05-002084
Filing Date
2005-03-02
Accepted
2005-03-02 08:49:00
Documents
2
Period of Report
2005-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS 8-K a4833957.txt 8-K 3369
2 EXHIBIT 99.1 PRESS RELEASE a4833957ex99.txt EX-99.1 22680
  Complete submission text file 0001157523-05-002084.txt   27909
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 05652348
SIC: 2835 In Vitro & In Vivo Diagnostic Substances